Word

BROKEN STRING

Status

Registered

Status Code

700

Status Date

Tuesday, June 11, 2024

Serial Number

79362453

Registration Number

7410776

Registration Date

Tuesday, June 11, 2024

Mark Type

4

Filing Date

Thursday, August 4, 2022

Published for Opposition

Tuesday, March 26, 2024

Trademark Owner History

BROKEN STRING BIOSCIENCES LIMITED - Original Registrant

Classifications

9 Downloadable computer software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; downloadable mobile application software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; apparatus and instruments for scientific or research purposes, namely, laboratory apparatus and instruments for genome sequencing, not for medical purposes

5 Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; pharmaceutical preparations for use in gene and cell therapies for the treatment of cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; pharmaceutical preparations for use in chemotherapies; diagnostic kits for medical purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; analytical test kits being medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders

1 Biological preparations for use in agriculture, except fungicides, herbicides, insecticides, and parasiticides

44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic blood testing for identifying and determining the presence and stage of diseases

10 Blood test collection kits comprised of blood collection needles, blood collecting tubes, and blood collection bags for medical purposes; radiation therapy devices

42 Analytical laboratory services, namely, scientific laboratory services; pharmaceutical research and development services; scientific research laboratory services relating to the manufacture of gene and cell therapies; scientific research laboratory services relating to biomanufacturing; scientific research laboratory services relating to bioscience manufacturing services; genome scientific research services; scientific research in the field of genome editing therapeutics; development of new technology for others in the field of medical devices and medical diagnostic apparatuses; medical research services; medical research in the field of infectious disease monitoring and surveillance services; research and development services in the field of antibodies; research and development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; medical research in the field of oncology; toxicity testing and analysis for foodstuffs for scientific research purposes; toxicity testing and analysis for household products for scientific research purposes; computer software development; providing temporary use of online non-downloadable software and software applications using artificial intelligence for medical analysis; software as a service (SaaS) featuring software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; platform as a service (PaaS) featuring computer software platforms for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; providing temporary use of on-line non-downloadable computer programs to access proprietary genomic datasets; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis

Trademark Events

Feb 9, 2023

Sn Assigned For Sect 66a Appl From Ib

Feb 11, 2023

New Application Office Supplied Data Entered

Feb 15, 2023

Application Filing Receipt Mailed

May 23, 2023

Assigned To Examiner

May 25, 2023

Non-Final Action Written

May 26, 2023

Non-Final Action (Ib Refusal) Prepared For Review

May 28, 2023

Limitation Of Goods Received From Ib

Jun 1, 2023

Non-Final Action (Ib Refusal) Withdrawn For Review

Jun 1, 2023

Non-Final Action Written

Aug 1, 2023

Refusal Processed By Ib

Jun 2, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Jul 11, 2023

Refusal Processed By Mpu

Jul 11, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Oct 14, 2023

Limitation From The Ib - Request Exam Review

Oct 16, 2023

Attorney Review Completed

Jan 5, 2024

Teas Response To Office Action Received

Jan 5, 2024

Correspondence Received In Law Office

Jan 5, 2024

Teas/Email Correspondence Entered

Feb 21, 2024

Examiners Amendment -Written

Feb 21, 2024

Examiners Amendment E-Mailed

Feb 21, 2024

Notification Of Examiners Amendment E-Mailed

Feb 21, 2024

Examiner's Amendment Entered

Feb 21, 2024

Approved For Pub - Principal Register

Mar 6, 2024

Notification Of Notice Of Publication E-Mailed

Mar 6, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 26, 2024

Published For Opposition

Mar 26, 2024

Official Gazette Publication Confirmation E-Mailed

Jun 11, 2024

Registered-Principal Register

Jun 11, 2024

Notice Of Registration Confirmation Emailed

Sep 11, 2024

Final Disposition Notice Created, To Be Sent To Ib